{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:28:31Z","timestamp":1793942911259,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["200581"],"award-info":[{"award-number":["200581"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.radonc.2026.111792","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:07:40Z","timestamp":1791151660000},"page":"111792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0168-2125","authenticated-orcid":false,"given":"Lena","family":"Kretzschmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Wallimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Obergfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tanadini-Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Pouymayou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Boss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9463-7640","authenticated-orcid":false,"given":"Sylwia","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-3400","authenticated-orcid":false,"given":"Andrea","family":"Bink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mayinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111792_b0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cncr.26494","article-title":"Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries","volume":"118","author":"Darefsky","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111792_b0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","article-title":"Improved survival time trends for glioblastoma using the SEER 17 population-based registries","volume":"107","author":"Koshy","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111792_b0015","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/neuonc\/noac193","article-title":"Prognostic validation of a new classification system for extent of resection in glioblastoma: areport of the RANO resect group","volume":"25","author":"Karschnia","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111792_b0025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111792_b0030","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2015.12.003","article-title":"ESTRO-ACROP guideline \u201ctarget delineation of glioblastomas\u201d","volume":"118","author":"Niyazi","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109663","article-title":"ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma","volume":"184","author":"Niyazi","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay system: magnetic resonance-guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0050","first-page":"98","article-title":"Technical design and concept of a 0.35 T MR-Linac","volume":"8","author":"Kl\u00fcter","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0055","doi-asserted-by":"crossref","unstructured":"Raaymakers BW, Lagendijk JJ, Overweg J, Kok JG, Raaijmakers AJ, Kerkhof EM, et al. Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept. Phys Med Biol. 2009 Jun 21;54(12):N229-37. doi: 10.1088\/0031-9155\/54\/12\/N01.","DOI":"10.1088\/0031-9155\/54\/12\/N01"},{"key":"10.1016\/j.radonc.2026.111792_b0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","article-title":"Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer","volume":"125","author":"Bohoudi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2020.02.025","article-title":"Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors","volume":"107","author":"Finazzi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111792_b0070","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/cancers15051555","article-title":"Simulated adaptive radiotherapy for shrinking glioblastoma resection cavities on a hybrid MRI-linear accelerator","volume":"15","author":"Guevara","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111792_b0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2018.10.003","article-title":"Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients","volume":"130","author":"Munck Af Rosenschold","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-025-05053-6","article-title":"Advancements in adaptive MR-guided radiotherapy for high-grade gliomas","volume":"174","author":"Marwaha","year":"2025","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111792_b0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijrobp.2025.02.020","article-title":"A phase 2 study of multiparametric magnetic resonance imaging-guided high-dose response-adaptive radiation therapy with concurrent temozolomide in patients with newly diagnosed glioblastoma: results from an interim analysis","volume":"122","author":"Kim","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111792_b0090","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2025. Available from: https:\/\/www.R-project.org\/, accessed 16th April 2026."},{"key":"10.1016\/j.radonc.2026.111792_b0095","unstructured":"Posit Team. RStudio: Integrated Development Environment for R. Posit Software, PBC, Boston, MA. 2025. Available from: https:\/\/www.posit.co\/, accessed 16th April 2026."},{"key":"10.1016\/j.radonc.2026.111792_b0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2024.09.028","article-title":"Dynamics of daily glioblastoma evolution during chemoradiation therapy on the 0.35T magnetic resonance imaging-linear accelerator","volume":"122","author":"Cullison","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111792_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2021.04.001","article-title":"Evolution of the gross tumour volume extent during radiotherapy for glioblastomas","author":"Bernchou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2020.10.002","article-title":"Quantitating interfraction target dynamics during concurrent chemoradiation for glioblastoma: a prospective serial imaging study","volume":"109","author":"Stewart","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111792_b0115","article-title":"Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5T MR-Linac in an Australian setting","volume":"19","author":"Jamora","year":"2026","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0120","doi-asserted-by":"crossref","unstructured":"Rivera AL, Pelloski CE, Gilbert MR, Colman H, De La Cruz C, Sulman EP, et al. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro Oncol. 2010 Feb;12(2):116-21. doi: 10.1093\/neuonc\/nop020. Epub 2009 Dec 14. Erratum in: Neuro Oncol. 2010 Jun;12(6):617.","DOI":"10.1093\/neuonc\/nop020"},{"key":"10.1016\/j.radonc.2026.111792_b0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-020-03661-y","article-title":"Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation","volume":"151","author":"Chan","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2026.111792_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-025-02778-6","article-title":"Adaptive radiation therapy for glioblastoma: clinical efficacy and recurrence patterns","author":"Matsuyama","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0135","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/neuonc\/noad258","article-title":"Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: a new future is on the horizon","volume":"26","author":"Tseng","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0140","article-title":"Magnetic resonance imaging in glioblastoma radiotherapy - beyond treatment adaptation","volume":"20","author":"Paczona","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1470-2045(26)00088-4","article-title":"MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial","volume":"27","author":"Detsky","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semradonc.2023.10.010","article-title":"Quantitative MRI on MR-linacs: towards biological image-guided adaptive radiotherapy","volume":"34","author":"van Houdt","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0155","article-title":"Diffusion-weighted imaging-derived parameters as quantitative imaging biomarkers in magnetic resonance-guided radiotherapy: a systematic review","volume":"26","author":"Yuan","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111792_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.103316","article-title":"Implementation and evaluation of a dynamic contrast-enhanced MR perfusion protocol for glioblastoma using a 0.35T MRI-Linac system","volume":"119","author":"Maziero","year":"2024","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2026.111792_b0165","doi-asserted-by":"crossref","unstructured":"Wallimann P, Wild P, Martirosian P, Schick F, Mayinger M, Boss A, et al. Adaptation of an arterial spin labeling sequence for the assessment of brain perfusion on a 0.35T MR-Linac. MAGMA. 2026 Feb 12. doi: 10.1007\/s10334-026-01326-x.","DOI":"10.1007\/s10334-026-01326-x"},{"key":"10.1016\/j.radonc.2026.111792_b0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijrobp.2025.02.008","article-title":"Magnetic resonance imaging relaxometry for glioblastoma response assessment during radiation therapy on a 0.35 T magnetic resonance imaging linear accelerator","volume":"122","author":"Lutsik","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:13:49Z","timestamp":1793942029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026006328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S0167814026006328"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111792","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111792"}}